Anti-SARS-CoV-2 Natural Products as Potentially Therapeutic Agents.

Frontiers in Pharmacology
Cheorl-Ho Kim

Abstract

Severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2), a β-coronavirus, is the cause of the recently emerged pandemic and worldwide outbreak of respiratory disease. Researchers exchange information on COVID-19 to enable collaborative searches. Although there is as yet no effective antiviral agent, like tamiflu against influenza, to block SARS-CoV-2 infection to its host cells, various candidates to mitigate or treat the disease are currently being investigated. Several drugs are being screened for the ability to block virus entry on cell surfaces and/or block intracellular replication in host cells. Vaccine development is being pursued, invoking a better elucidation of the life cycle of the virus. SARS-CoV-2 recognizes O-acetylated neuraminic acids and also several membrane proteins, such as ACE2, as the result of evolutionary switches of O-Ac SA recognition specificities. To provide information related to the current development of possible anti-SARS-COV-2 viral agents, the current review deals with the known inhibitory compounds with low molecular weight. The molecules are mainly derived from natural products of plant sources by screening or chemical synthesis via molecular simulations. Artificial intelligence-...Continue Reading

References

Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R VlasakP Palese
Nov 1, 1993·Journal of Virology·C SöderbergE Möller
Dec 1, 1995·Journal of Ethnopharmacology·A R McCutcheonG H Towers
May 4, 2000·Journal of Agricultural and Food Chemistry·S H HäkkinenA R Törrönen
Jul 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·S HeinoE Ikonen
Jun 21, 2001·Journal of Agricultural and Food Chemistry·K H Miean, S Mohamed
Jan 5, 2002·Journal of Virology·Fumihiro Taguchi, Shutoku Matsuyama
Nov 5, 2002·Journal of Virology·Shutoku Matsuyama, Fumihiro Taguchi
Oct 31, 2003·Proceedings of the National Academy of Sciences of the United States of America·Haitao YangZihe Rao
Jul 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Chung-Yi WuChi-Huey Wong
Jul 29, 2004·Journal of Virology·Ryuji NomuraToyoshi Fujimoto
Feb 3, 2005·Chemical & Pharmaceutical Bulletin·Ya-Ching ShenPei-Wen Cheng
Feb 8, 2005·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·S M WittemerM Veit
Feb 18, 2005·Journal of Medicinal Chemistry·Gerold HoeverJindrich Cinatl
Jun 7, 2005·Evidence-based Complementary and Alternative Medicine : ECAM·Chia-Nan ChenJohn T-A Hsu
Jun 23, 2006·Clinical and Experimental Pharmacology & Physiology·Pei-Win ChengChun-Ching Lin
Mar 17, 2007·Journal of Asian Natural Products Research·Q-Y YangW-S Fang
Nov 27, 2007·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Hye-Young KimKyongmin Kim
Mar 22, 2008·Chemistry & Biodiversity·Monica R LoizzoHans Wilhelm Doerr
May 16, 2008·Journal of Ethnopharmacology·Kit-Man LauKwok-Pui Fung
Sep 3, 2008·Journal of Ethnopharmacology·Chung-Jen ChenHans Wilhelm Doerr
Oct 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kiira RatiaAndrew D Mesecar
Nov 11, 2008·Antiviral Research·Hwa-Jung ChoiDur-Han Kwon
May 12, 2009·Antiviral Research·Min ZhuangToshio Hattori

❮ Previous
Next ❯

Software Mentioned

Toxtree

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.